Publication | Closed Access

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Prognostic BiomarkersCancer ImmunosurveillancePd-l1 ExpressionMedicineCirculating Tumor CellsImmune Checkpoint InhibitorsImmunologyTumor ImmunityBiomarker TargetImmune SurveillanceImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyLung Cancer